Is novartis.gr Safe? Security Analysis for Novartis Greece
https://novartis.grCheck if novartis.gr is a scam or legitimate. Free security scan and reviews.
Above Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for novartis.gr
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Novartis Greece operates as a regional branch of the global pharmaceutical leader Novartis AG, focusing on redefining medical practice through innovative scientific data and digital technologies. The company targets improving and extending human lives by developing pioneering therapies addressing significant medical needs. The website reflects a mature digital presence with localized Greek content, professional design, and comprehensive compliance with privacy and cookie regulations. Technically, the site is built on Drupal CMS, integrates modern analytics and marketing tools, and demonstrates good performance and accessibility standards. Security posture is strong with HTTPS enforcement, security headers, and no visible vulnerabilities, although public security policies and incident response contacts are not explicitly published. The absence of WHOIS data is a notable anomaly but does not undermine the site's legitimacy given the corporate branding and content quality. Overall, Novartis Greece's website is a trustworthy, professional platform supporting its business objectives in the healthcare sector.
Detected Technologies
8 urgent findings need attention
8 high
Keep novartis.gr under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
4 findings
65/100
GDPR Compliance
1 finding
88/100
NIS2 Compliance
9 findings
2/100
Email Security
3 findings
85/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Novartis Greece holds a strong market position as part of a top global pharmaceutical company, leveraging innovation and digital transformation to serve medical needs in Greece. The business model centers on pharmaceutical research, development, and commercialization of advanced therapies. The company targets healthcare professionals, patients, and stakeholders interested in medical advancements. The website's structured data and social media presence reinforce its corporate identity and outreach. The use of multiple analytics and marketing tools indicates a data-driven approach to customer engagement and market intelligence. The lack of visible subsidiaries or partner domains suggests a focused regional operation under the global Novartis umbrella.
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a mature security posture with enforced HTTPS, presence of key security headers, and secure form implementations. No exposed sensitive data or vulnerable libraries were detected in the HTML content. However, the absence of a public security policy page, incident response contacts, and vulnerability disclosure mechanisms indicates room for improvement in transparency and incident readiness. Compliance with GDPR is evident through privacy and cookie policies with consent mechanisms. The integration of third-party analytics and marketing scripts is managed with user consent, mitigating privacy risks. Overall, the security maturity is good but could be enhanced by publishing explicit security governance documents and contact channels.
Strategic Recommendations
Priority Actions for Security Improvement
Publish a dedicated security policy page outlining security practices and commitments.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Novartis Greece
Σκοπός μας είναι να επαναπροσδιορίζουμε την ιατρική πρακτική, για να βελτιώσουμε και να επεκτείνουμε τις ζωές των ανθρώπων.Ως κορυφαία παγκόσμια φαρμακευτική εταιρεία, αξιοποιούμε καινοτόμα επιστημονικά δεδομένα και ψηφιακές τεχνολογίες για την ανάπτυξη πρωτοποριακών θεραπειών που κάνουν τη διαφορά σε τομείς, όπου υπάρχει μεγάλη ιατρική ανάγκη.
excellent
consistent
Technical Stack
moderate
good
good
good
Security Assessment
- HTTPS enforced
- Content Security Policy present
- No exposed sensitive data in HTML
- Secure forms with autocomplete off
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is fully accessible with no blocking or WAF challenge.
Get this report delivered to your inbox
Receive a summary of the novartis.gr security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Critical sector without clear security compliance
HIGHDetected sectors: energy, transport, health, digital
Need this report as a PDF?
Download the complete novartis.gr security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
SPF Details
DKIM Selectors Found
DMARC Details
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 35 days
Weak SSL Key Length
HIGHSSL certificate uses 256-bit key, which is considered weak
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
Domain Registration Details
DNS Records
DNSSEC Status
DNS Performance
SPF Analysis
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does novartis.gr compare?
See how novartis.gr stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the novartis.gr report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the novartis.gr report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about novartis.gr
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published